+Advanced Search
Home > Archive>Volume 25, Issue 2, 2015 >67-70. DOI:10.3969.j.issn.1671.7856. 2015.002.016
PDF HTML XML Export Cite reminder
Advances and application of induced neural stem cells
CSTR:
[cstr]
Author:
  • Article
    • | |
  • Metrics
    • |
  • Reference [38]
    • | | | |
  • Comments
    Abstract:

    It has been reported that induced neural stem cells(iNSCs) can be obtained from rodent and human somatic cells through the forced expression of defined factors. Two different approaches have been successfully used to obtain iNSCs:a direct method and an indirect method which involves an unstable intermediate state.Compared with induced pluripotent stem cells (iPSCs) and embryonic stem cells(ESCs),iNSCs are committed towards neural lineage, enabling them with a lower risk of tumorigenicity and more efficient transdifferentiation which makes it suitable for clinical use in the future.

    Reference
    [1] Wernig M., Zhao JP, Pruszak J, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease [J]. Proc Natl Acad Sci U S A, 2008,105(15): 5856-5861.
    [2] Dimos JT., Rodolfa KT, Niakan KK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons [J]. Science, 2008, 321(5893): 1218-1221.
    [3] Moghadam FH, Alaie H, Karbalaie K, et al. Transplantation of primed or unprimed mouse embryonic stem cell-derived neural precursor cells improves cognitive function in Alzheimerian rats [J]. Differentiation, 2009,78(2-3): 59-68.
    [4] Corti S, Nizzardo M, Nardini M, et al. Neural stem cell transplantation can ameliorate the phenotype of a mouse model of spinal muscular atrophy [J]. J Clin Invest, 2008,118(10): 3316-3330.
    [5] Lunn JS, Sakowski SA, Federici T, et al. Stem cell technology for the study and treatment of motor neuron diseases [J]. Regen Med, 2011, 6(2): 201-213.
    [6] Nandoe Tewarie RS, Hurtado A, Bartels RH, et al. Stem cell-based therapies for spinal cord injury [J]. J Spinal Cord Med, 2009,32(2): 105-114.
    [7] Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors [J]. Cell, 2006,126(4): 663-676.
    [8] Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors [J]. Cell, 2007,131(5): 861-872.
    [9] Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state [J]. Nature, 2007, 448(7151): 318-324.
    [10] Lujan E, Chanda S, Ahlenius H, et al. Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells [J]. Proc Natl Acad Sci U S A, 2012,109(7): 2527-2532.
    [11] Sheng C, Zheng Q, Wu J,et al. Direct reprogramming of Sertoli cells into multipotent neural stem cells by defined factors [J]. Cell Res, 2012, 22(1): 208-218.
    [12] Han DW, Tapia N, Hermann A,et al. Direct reprogramming of fibroblasts into neural stem cells by defined factors [J]. Cell Stem Cell, 2012,10(4): 465-472.
    [13] Ring KL, Dong LM, Balestra RJ, et al. Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor [J]. Cell Stem Cell, 2012,11(1): 100-109.
    [14] Zhu S, Ambasudham R, Sun W, et al. Small molecules enable OCT4-mediated direct reprogramming into expandable human neural stem cells [J]. Cell Res, 2014, 24(1): 126-129.
    [15] Kim SM, Flakamp H, Hermann A,et al. Direct conversion of mouse fibroblasts into induced neural stem cells [J]. Nat Protoc, 2014,9(4): 871-881.
    [16] Kim J, Efe JA, Zhu S,et al. Direct reprogramming of mouse fibroblasts to neural progenitors [J]. Proc Natl Acad Sci U S A, 2011,108(19): 7838-7843.
    [17] Wang L, Wang LL, Huang WH, et al. Generation of integration-free neural progenitor cells from cells in human urine [J]. Nat Methods, 2013, 10(1): 84-89.
    [18] Lu J, Liu H, Huang CT, et al. Generation of integration-free and region-specific neural progenitors from primate fibroblasts [J]. Cell Rep, 2013,3(5): 1580-15891.
    [19] Nakagawa M, Kojanagi M, Tanabe K, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts [J]. Nat Biotechnol, 2008, 26(1): 10110-10116.
    [20] Anokye-DansoF, Trivedi CM, Juhr D, et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency [J]. Cell Stem Cell, 2011,8(4): 376-388.
    [21] Hou P, Li Y, Zhang X,et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds [J]. Science, 2013,341(6146): 651-654.
    [22] Loh YH, Hartung O, Li H,et al. Reprogramming of T cells from human peripheral blood [J]. Cell Stem Cell, 2010,7(1): 15-19.
    [23] Staerk J, Dawlaty MM, Gao Q,et al. Reprogramming of human peripheral blood cells to induced pluripotent stem cells [J]. Cell Stem Cell, 2010,7(1): 20-24.
    [24] Dowey SN, Huang X, Chou BK,et al. Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression [J]. Nat Protoc, 2012,7(11): 2013-2021.
    [25] Kim JH, Auerbach JM, Rodríguez-Gómez JA,et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease [J]. Nature, 2002,418(6893): 50-56.
    [26] Dunnett SB, Rosser AE. Stem cell transplantation for Huntington's disease [J]. Exp Neurol, 2007, 203(2): 279-292.
    [27] Pluchino S, Quattrini A, Brambilla E,et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis [J]. Nature, 2003,422(6933): 688-694.
    [28] Taguchi A, Soma T, Tanaka H,et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model [J]. J Clin Invest, 2004,114(3): 330-338.
    [29] Schira J, Gasis M, Estrada V,et al. Significant clinical, neuropathological and behavioural recovery from acute spinal cord trauma by transplantation of a well-defined somatic stem cell from human umbilical cord blood [J]. Brain, 2012,135(Pt 2): 431-446.
    [30] Freed CR, Greene PE, Breeze RE,et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease [J]. N Engl J Med, 2001,344(10): 710-719.
    [31] Cicchetti F, Saporta S, Hauser RA,et al. Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration [J]. Proc Natl Acad Sci U S A, 2009, 106(30): 12483-12488.
    [32] YamoutB, Hourani R, Salti H,et al. Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study [J]. J Neuroimmunol, 2010,227(1-2): 185-189.
    [33] Lee JS, Hong JM, Moon GJ, et al. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke [J]. Stem Cells, 2010, 28(6): 1099-1106.
    [34] Miura K, Okada Y, Aoi T, et al. Variation in the safety of induced pluripotent stem cell lines [J]. Nat Biotechnol, 2009,27(8): 743-745.
    [35] Yamanaka S. A fresh look at iPS cells [J]. Cell, 2009,137(1): 13-17.
    [36] Son EY, Ichida JK, Wainger BJ, et al. Conversion of mouse and human fibroblasts into functional spinal motor neurons [J]. Cell Stem Cell, 2011, 9(3):205-218.
    [37] Tsuji O, Miura K, Okada Y, et al. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury [J]. Proc Natl Acad Sci U S A, 2010,107(28): 12704-12709.
    [38] Zhao TB, Zhang ZN, Rong ZL, et al. Immunogenicity of induced pluripotent stem cells [J]. Nature, 2011,474(7350): 212-215.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Copy
Share
Article Metrics
  • Abstract:2627
  • PDF: 2486
  • HTML: 0
  • Cited by: 0
History
  • Revised:November 05,2014
  • Online: March 04,2015
Article QR Code
You are the first3035429 Visitors
® 2025 All Rights Reserved
Address：5 Panjiayuan Nanli, Chaoyang District, Beijing 100021, China Postcode： Phone：86-10-67779337 E-mail:bjb@cnilas.org
Supported by:Beijing E-Tiller Technology Development Co., Ltd.